Material and Methods
Intranasal delivery of encapsulated clodronate liposomes is a well-established method to selectively deplete lung macrophages with peak depletion occurring after 24 h and persisting up to 5 days (5-7). Clodronate was a gift of Roche Diagnostics GmbH (Mannheim, Germany).
Clodronate and phosphate-buffered saline (PBS) were encapsulated in liposomes as previously described (8) . Others have recently shown that administration of 30 μl (as opposed to 100 μl) of encapsulated clodronate liposomes is well-tolerated in mice, yet still effectively depletes lung macrophages (6). Mice were treated intranasally with 30 μl of clodronate liposomes (CL-LIP) (6, 9) under light anesthesia 48 h prior to initial DE challenge. For the repetitive exposure studies, mice continued to receive intranasal liposomes every 3-4 days throughout the 3 week repetitive DE period to maintain macrophage depletion, since DE elicits macrophage recruitment to the lung (4). Macrophage depletion was confirmed in BALF by enumeration of differential cell counts on cytospun-prepared slides stained with DiffQuick (10, 11). Using methodology modified from Gibbons and colleagues (12) , interstitial lung macrophage depletion was confirmed by staining lung sections with H&E and lung macrophages in peripheral and central lung fields (10 total fields/section) were counted and averaged per individual mouse. For the repetitive exposure model, interstitial CD11c + lung macrophage depletion was determined by flow cytometry as detailed below and Supplemental Figure 1A . Differences in weight gain were monitored in both CL-LIP and SL-LIP treatment groups. In the current and previous studies (4, 13, 14) , mice receiving repetitive DE or saline gained weight during the 3 week exposure duration; however, in these studies, mice receiving clodronate liposomes every 3-4 day for 3 weeks failed to gain weights at equivalent rates. The average weight (gm) gain ± SD per animal group was saline only: 1.2 ± 0.6; SL-LIP + DE: 1.4 ± 0.8; CL-LIP + saline: 0.4 ± 0.8; and CL-LIP + DE: 0.4 ±0.8. Despite this lag in weight gain with clodronate liposome treatment, none of the mice exhibited any signs of distress.
Lung cell isolation
Cells were isolated from whole lungs as previously described (13). Briefly, 24 hr after final treatment condition, animals were euthanized, lungs were lavaged (1 ml x 3) and BALF was discarded. Next, after exposing the chest cavity, the right ventricle was infused with 10 ml of sterile PBS to remove blood from the pulmonary vasculature. Whole lung tissues were harvested and subjected to an automated dissociation procedure using a gentleMAC Dissociator instrument according to the manufacturer's instructions (Miltenyi Biotech, Auburn, CA) in a solution containing collagenase type I (324 U/mL; Fisher, Pittsburgh, PA), bovine DNase (75 U/mL), porcine heparin (25 U/mL) and PBS with Ca 2+ and Mg 2+ . The resulting solution was passed through nylon mesh (40 μM; Fisher) to remove any large fragments, and cell pellets were briefly resuspended in cold RBC lysing solution, centrifuged, and cell counts were obtained by hematocytometer and recorded. Viability was assessed and assured by trypan blue exclusion. In addition, less than 1% of the CD11c + gated macrophages (Supplemental Figure 1A) were dead as determined by the LIVE/DEAD Fixable Violet Dead Cell Stain kit (Life Technologies, Carlsbad CA) with no difference between saline and DE-treated groups.
Phagocytosis Assay
The phagocytic capacity of lung-associated-CD11c + cells was assessed by flow cytometry modified from previously published methods (15, 16) . Briefly, 5 x 10 5 whole lung cells/100 μl were first stained with CD11c and Ly-6G for 15 min and subsequently washed and incubated with FITC-labeled Saccharomyces cerevisiae zymosan A Bioparticles (Molecular Probes, Inc.) opsonized with IgG in the presence of 10% murine serum for 0 and 60 min. Flow cytometric analyses was performed with a FACSCalibur dual-laser cytometer (Becton-Dickinson, Lincoln Park, NJ). Particle uptake in the CD11c + (Ly-6G -) gated population was identified as a rightward shift in fluorescence, and phagocytic ability was determined by assessing the average mean fluorescence intensity (MFI) from the proportion of cells in the zymosan-exposed population at 60 min as compared to cells exposed for 0 min (expressed as fold-change in MFI).
Cytokine Assay
Isolated CD11c + lung cells from mice repetitively exposed to saline and DE was analyzed for ex vivo cytokine/chemokine responsiveness to subsequent DE re-stimulation by ELISA with details provided in the online supplement. Briefly, single cell suspensions of whole lung cells were underlaid with lymphocyte separation solution (Fisher Scientific, Pittsburgh, PA) and centrifuged at 400 g for 20 min. Mononuclear cells were incubated in PBS containing 0.1% BSA with anti-CD16/32 (Fc Block), and stained with a mAB directed against CD11c and fluorescence-activated cell sorting using a FACSAria (BD Biosciences). Post-sort analysis confirmed >95% purity. Next, 1 x 10 5 cells/100 μl was stimulated with 1% DE or saline for 24 h, and cell-free supernatants were harvested for cytokine/chemokine expression by sandwich ELISA. After stimulation (i.e. 24 h post), cell viability was determined by trypan blue exclusion.
TNF-α, IL-6, keratinocyte chemoattractant (KC; CXCL1), and macrophage inflammatory protein-2 (MIP-2; CXCL2) concentrations were determined according to manufacturer's instructions using commercially available ELISA kits (R&D Systems) and reported as concentration (pg/mL) with sensitivities of 10.9, 7.8, 15.6, 7.8 pg/mL, respectively.
Immunohistochemistry
Formalin-fixed, paraffin-embedded sections of 4-5 μm-thick tissue were deparaffinized through 2 exchanges of xylene, and rehydrated using a graded series of alcohol washes (100%, 95%, 80%, 50% ethanol) and rinsed twice in PBS. Antigen unmasking was performed using the heat-induced epitope retrieval method. Slides were immersed in pre-heated antigen retrieval solution (DIVA Decloaker solution; Biocare Medical, Concord, CA) and steamed for 30 minutes at 95°C in a vegetable steamer. After cooling, slides were rinsed with TBST washing buffer (Tris-based with sodium chloride and Tween-20). Endogenous peroxidase activity was quenched with Peroxo-Block (Zymed Laboratories, South San Francisco, CA). After washing, slides were blocked for 20 minutes in a humidity chamber in 10% normal goat serum (Vector, Burlingame, CA) before application of primary antibodies. Slides were incubated with the primary antibody, anti-TNF-α (dilution 1:200, Thermo Scientific, Rockford, IL) for one hour at room temperature. After washing, slides were incubated with biotinylated goat-anti-rabbit IgG (Vector, Burlingame, CA) secondary antibody. After 30 mininutes, slides were rinsed and primary antibody binding was detected using the avidin-biotin-immunoperoxidase method (Vectastain Elite ABC ready-to-use kit; Vector). Chromogen substrate (IMMPACT DAB; Vector) developer was used and slides were counterstained with 1% Meyers Hematoxylin.
Results

TNF-α expression in airway epithelial cells
Formalin-fixed, paraffin-embedded lung sections from the repetitive exposure treatment groups in the setting of saline and clodronate liposome treatment were analyzed by immunohistochemistry to determine if airway epithelial cells were a potential source of TNF-α.
Positive TNF-α staining was observed in airway epithelial cells in all groups with no discernible difference between groups (Supplemental Figure 3) .
Supplemental Figures
Supplemental Figure 1A-B . Gating strategy for enumeration of cell populations by flow cytometry. C57BL/6 mice were repetitively exposed to organic DE or saline for 3 weeks whereupon cells were isolated from whole lungs. Lung-associated cells were incubated with anti-CD16/32 (Fc Block) to minimize non-specific Ab binding, and then simultaneously stained for 1) CD11c, CD11b, IA-b, CD80, CD86, and Ly-6G. C57BL/6 mice were treated with clodronate liposomes (CL-LIP) or saline liposomes (SL-LIP) beginning 2 days prior to the first DE challenge and subsequently every 3-4 days during the daily 3 week repetitive DE and lung sections were stained with anti-TNF-α antibody by immunohistochemical methods. A representative 4-to 5-μm-thick section from each group is shown. A secondary antibody alone (no primary antibody) control is also shown. By microscopic review, there were no discernible differences in airway epithelial TNF-α staining between groups. Figure 1A 
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